Mediclin AG Stock
Mediclin AG Stock
A loss of -2.730% shows a downward development for Mediclin AG.
So far the community has only identified positive things for Mediclin AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Mediclin AG in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mediclin AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Mediclin AG | -2.730% | 5.172% | 4.571% | 25.342% | 2.235% | 21.192% | -14.486% |
| Vita 34 AG | -4.110% | -1.794% | -6.410% | 11.735% | -28.197% | -38.655% | -73.293% |
| M1 Kliniken AG | 1.250% | 7.730% | 15.223% | 17.852% | -8.542% | 136.022% | 71.317% |
| Healthstream Inc. | 0.000% | 12.568% | 17.714% | -30.405% | 5.641% | -4.630% | -3.738% |
News
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN increases group operating result in the first quarter
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results
EQS-News: MEDICLIN lays a solid foundation for further growth with its 2025 financial results
EQS-News: MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025
EQS-News: MEDICLIN invites you to the 2026 virtual press conference on the financial statements for the year 2025